Yonatan Bilu
Research Subjects
Research Interests
Yonatan Bilu has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Pinchas Akiva
KI Research Institute, Kfar Malal, Israel
4 shared publicationsGilad Bodenheimer
Maccabi Healthcare Services, Tel-Aviv, Israel
3 shared publicationsMaytal Bivas-Benita
KI Research Institute, Kfar-Malal, Israel
3 shared publicationsMiri Mizrahi-Reuveni
Maccabi Healthcare Services, Tel-Aviv, Israel
3 shared publicationsNir Kalkstein
KI Research Institute, Kfar Malal, Israel
3 shared publicationsShira Greenfeld
Maccabi Healthcare Services, Tel-Aviv, Israel
3 shared publications
Latest Publications
- Open Access
- 26 January 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 24
Peripartum psychiatric admissions in Israel: A retrospective cohort study
- 26 January 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 24
Open AccessPeripartum psychiatric admissions in Israel: A retrospective cohort study
- Open Access
- 3 January 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Data driven versus standard practice policies for personalized antidepressant treatment: a retrospective cohort study of electronic health records
Depression is a heterogenous condition, with high societal and economic costs. Response to available treatments is varied, often trial-and-error, raising t
- 3 January 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessData driven versus standard practice policies for personalized antidepressant treatment: a retrospective cohort study of electronic health records
Depression is a heterogenous condition, with high societal and economic costs. Response to available treatments is varied, often trial-and-error, raising t
- Open Access
- 1 October 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (10) , e2539441
Differentiating Transient From Persistent Developmental Delays in a Nationwide Infant Cohort
Importance: Early childhood developmental surveillance is critical for identifying children at risk of developmental delays and ensuring timely intervention. Current well-child surveillance policies are not well designed to distinguish transient delays from persistent ones, potentially leading to unnecessary referrals or missed opportunities for early support. Objective: To evaluate whether the Tipat Halav Israeli Surveillance (THIS) developmental scale can be leveraged for distinguishing transient from persistent developmental delays and thus augment the precision of early childhood surveillance policies. Design, Setting, and Participants: This retrospective cohort study used national data from maternal child health clinics in Israel that perform routine developmental surveillance of children aged 0 to 6 years, serving approximately 65% of Israeli children. Participants were individuals born at 37 weeks’ gestation or later in the years 2014 to 2022 and assessed between January 1, 2014, and December 31, 2022, who failed to attain at least 1 developmental milestone between age 9 and 12 months based on their electronic health records. Analysis was done between July 2024 and April 2025. Exposure: Age-appropriate milestone attainment results at ages 9 to 12 months, along with demographic and birth-related covariates. Main Outcome and Measures: The primary outcome was ongoing milestone attainment failure at age 12 to 24 months. Accuracy of machine learning models trained to predict the outcome was measured by the area under the receiver operating characteristic curve, while for simpler decision rules, sensitivity and specificity were computed. Results: In a cohort of 529 797 infants born at 37 weeks’ gestation or later and assessed at age 9 to 12 months, developmental delays were observed in 37 760 (7.1%), among whom 20 862 (55.2%) were male and median gestational age was 39 weeks (IQR, 38-40 weeks). A total of 35 163 (93.1%) were assessed again in their subsequent year of life, among whom persistent delay was suggested for 8802 (25.0%). Machine learning models distinguished transient from persistent delays, with areas under the receiver operating characteristic curve ranging from 0.71 (95% CI, 0.70-0.72) to 0.77 (95% CI, 0.74-0.79). Simply counting the number of developmental domains in which unmet milestones occurred showed good fidelity as well (eg, sensitivity of 0.48 and specificity of 0.81 to identify persistent gross motor delay after early milestone failure in that domain plus 1 other). Conclusions and Relevance: This cohort study of infants showing early signs of developmental delay suggests that transient delays can be effectively distinguished from persistent ones using routine well-child surveillance data and also provides evidence for the validity of counting domains in which milestones are not attained, which is often used in practice. This suggests an accessible approach for developmental surveillance that may improve outcomes for children worldwide.
- 1 October 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (10) , e2539441
Open AccessDifferentiating Transient From Persistent Developmental Delays in a Nationwide Infant Cohort
Importance: Early childhood developmental surveillance is critical for identifying children at risk of developmental delays and ensuring timely intervention. Current well-child surveillance policies are not well designed to distinguish transient delays from persistent ones, potentially leading to unnecessary referrals or missed opportunities for early support. Objective: To evaluate whether the Tipat Halav Israeli Surveillance (THIS) developmental scale can be leveraged for distinguishing transient from persistent developmental delays and thus augment the precision of early childhood surveillance policies. Design, Setting, and Participants: This retrospective cohort study used national data from maternal child health clinics in Israel that perform routine developmental surveillance of children aged 0 to 6 years, serving approximately 65% of Israeli children. Participants were individuals born at 37 weeks’ gestation or later in the years 2014 to 2022 and assessed between January 1, 2014, and December 31, 2022, who failed to attain at least 1 developmental milestone between age 9 and 12 months based on their electronic health records. Analysis was done between July 2024 and April 2025. Exposure: Age-appropriate milestone attainment results at ages 9 to 12 months, along with demographic and birth-related covariates. Main Outcome and Measures: The primary outcome was ongoing milestone attainment failure at age 12 to 24 months. Accuracy of machine learning models trained to predict the outcome was measured by the area under the receiver operating characteristic curve, while for simpler decision rules, sensitivity and specificity were computed. Results: In a cohort of 529 797 infants born at 37 weeks’ gestation or later and assessed at age 9 to 12 months, developmental delays were observed in 37 760 (7.1%), among whom 20 862 (55.2%) were male and median gestational age was 39 weeks (IQR, 38-40 weeks). A total of 35 163 (93.1%) were assessed again in their subsequent year of life, among whom persistent delay was suggested for 8802 (25.0%). Machine learning models distinguished transient from persistent delays, with areas under the receiver operating characteristic curve ranging from 0.71 (95% CI, 0.70-0.72) to 0.77 (95% CI, 0.74-0.79). Simply counting the number of developmental domains in which unmet milestones occurred showed good fidelity as well (eg, sensitivity of 0.48 and specificity of 0.81 to identify persistent gross motor delay after early milestone failure in that domain plus 1 other). Conclusions and Relevance: This cohort study of infants showing early signs of developmental delay suggests that transient delays can be effectively distinguished from persistent ones using routine well-child surveillance data and also provides evidence for the validity of counting domains in which milestones are not attained, which is often used in practice. This suggests an accessible approach for developmental surveillance that may improve outcomes for children worldwide.
- Open Access
- 1 August 2025
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 28 (6) , 1571-1584
Maternal psychiatric admissions and Child developmental delays: A nationwide cohort study
Purpose Children of mothers experiencing mental illness are known to exhibit elevated rates of developmental delays. However, there is little evidence-based research on the impact of perinatal psychiatric admissions. Here we aim to quantify the association between maternal mental illness that leads to admission, and the likelihood of child developmental delay. In addition, we aim to understand the association between the timing of admission, the maternal diagnosis and the developmental domain in which delays manifest. Methods Retrospective cohort study of data from well-child visits of 634,918 term-born children assessed between 2016 and 2022 at the ages of 1 to 36 months. Likelihood of failure in milestone attainment was modelled based on maternal psychiatric information available through the national registry, and adjusted for demographic and birth data from the Israeli national program of Maternal Child Health Clinics. Secondary analyses examined stratification by maternal diagnosis, timing of admission and developmental domain, as well as comparison to the association between the likelihood of child developmental delay and maternal high scores on the Edinburgh Postnatal Depression Scale. Results Maternal mental illness that leads to psychiatric admission was associated with an increased odds ratio for child developmental delay (OR ~ 1.7). Higher odds ratio was associated with psychotic disorders diagnoses, multiple admissions and admissions between birth and child assessment. Nonetheless, increased odds were suggested also when first admission occurred after child assessment. In addition, increased odds were more evident when children were assessed at an older age. Conclusions Children of mothers experiencing mental illness exhibit higher rates of developmental delays, especially when mothers are admitted. Identifying and supporting high-risk dyads during the peripartum period is therefore critical for both mother and child.
- 1 August 2025
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 28 (6) , 1571-1584
Open AccessMaternal psychiatric admissions and Child developmental delays: A nationwide cohort study
Purpose Children of mothers experiencing mental illness are known to exhibit elevated rates of developmental delays. However, there is little evidence-based research on the impact of perinatal psychiatric admissions. Here we aim to quantify the association between maternal mental illness that leads to admission, and the likelihood of child developmental delay. In addition, we aim to understand the association between the timing of admission, the maternal diagnosis and the developmental domain in which delays manifest. Methods Retrospective cohort study of data from well-child visits of 634,918 term-born children assessed between 2016 and 2022 at the ages of 1 to 36 months. Likelihood of failure in milestone attainment was modelled based on maternal psychiatric information available through the national registry, and adjusted for demographic and birth data from the Israeli national program of Maternal Child Health Clinics. Secondary analyses examined stratification by maternal diagnosis, timing of admission and developmental domain, as well as comparison to the association between the likelihood of child developmental delay and maternal high scores on the Edinburgh Postnatal Depression Scale. Results Maternal mental illness that leads to psychiatric admission was associated with an increased odds ratio for child developmental delay (OR ~ 1.7). Higher odds ratio was associated with psychotic disorders diagnoses, multiple admissions and admissions between birth and child assessment. Nonetheless, increased odds were suggested also when first admission occurred after child assessment. In addition, increased odds were more evident when children were assessed at an older age. Conclusions Children of mothers experiencing mental illness exhibit higher rates of developmental delays, especially when mothers are admitted. Identifying and supporting high-risk dyads during the peripartum period is therefore critical for both mother and child.
- 4 April 2025
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 34 (9) , 2825-2832
Trends in antipsychotic treatment of children and adolescents in Israel from post-mental health reform to post-COVID19 pandemic (2015–2023)
This study investigates the patterns of antipsychotic drug dispensations among children and adolescents from 2015 to 2023, with a focus on the impact of introducing national health reform (2015) and the COVID-19 pandemic. Data from Maccabi Healthcare Services, encompassing 1,105,439 individuals aged 6–18 years, were analyzed using a retrospective cohort study. We investigated the incidence rates of antipsychotic prescriptions by age, sex, socioeconomic status, and geographical region. During the study period, there was a 15% overall increase in antipsychotics prescriptions. Higher prescription rates were observed among boys aged 6–11 years and girls aged 14–18 years. Significant increases in prescriptions were observed in the year immediately following the mental health reform and the COVID-19 pandemic. Low socioeconomic status and peripheral regions exhibited higher and increasing prescription rates. Seasonal patterns revealed peaks in the fourth quarter of each year. The study highlights an overall increase in antipsychotic prescriptions, influenced by policy changes and the pandemic. Inequality in prescription rates by socioeconomic status and geographical location underscores the need for targeted mental health interventions. The findings also suggest enduring changes in the utilization of antipsychotic medications among youth, which may reflect broader impacts of the COVID-19 pandemic on mental health care needs.
- 4 April 2025
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 34 (9) , 2825-2832
Trends in antipsychotic treatment of children and adolescents in Israel from post-mental health reform to post-COVID19 pandemic (2015–2023)
This study investigates the patterns of antipsychotic drug dispensations among children and adolescents from 2015 to 2023, with a focus on the impact of introducing national health reform (2015) and the COVID-19 pandemic. Data from Maccabi Healthcare Services, encompassing 1,105,439 individuals aged 6–18 years, were analyzed using a retrospective cohort study. We investigated the incidence rates of antipsychotic prescriptions by age, sex, socioeconomic status, and geographical region. During the study period, there was a 15% overall increase in antipsychotics prescriptions. Higher prescription rates were observed among boys aged 6–11 years and girls aged 14–18 years. Significant increases in prescriptions were observed in the year immediately following the mental health reform and the COVID-19 pandemic. Low socioeconomic status and peripheral regions exhibited higher and increasing prescription rates. Seasonal patterns revealed peaks in the fourth quarter of each year. The study highlights an overall increase in antipsychotic prescriptions, influenced by policy changes and the pandemic. Inequality in prescription rates by socioeconomic status and geographical location underscores the need for targeted mental health interventions. The findings also suggest enduring changes in the utilization of antipsychotic medications among youth, which may reflect broader impacts of the COVID-19 pandemic on mental health care needs.
- Open Access
- 18 August 2023
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 9, e47315
A Developmental Surveillance Score for Quantitative Monitoring of Early Childhood Milestone Attainment: Algorithm Development and Validation
Background: Developmental surveillance, conducted routinely worldwide, is fundamental for timely identification of children at risk of developmental delays. It is typically executed by assessing age-appropriate milestone attainment and applying clinical judgment during health supervision visits. Unlike developmental screening and evaluation tools, surveillance typically lacks standardized quantitative measures, and consequently, its interpretation is often qualitative and subjective. Objective: Herein, we suggested a novel method for aggregating developmental surveillance assessments into a single score that coherently depicts and monitors child development. We described the procedure for calculating the score and demonstrated its ability to effectively capture known population-level associations. Additionally, we showed that the score can be used to describe longitudinal patterns of development that may facilitate tracking and classifying developmental trajectories of children. Methods: We described the Developmental Surveillance Score (DSS), a simple-to-use tool that quantifies the age-dependent severity level of a failure at attaining developmental milestones based on the recently introduced Israeli developmental surveillance program. We evaluated the DSS using a nationwide cohort of >1 million Israeli children from birth to 36 months of age, assessed between July 1, 2014, and September 1, 2021. We measured the score’s ability to capture known associations between developmental delays and characteristics of the mother and child. Additionally, we computed series of the DSS in consecutive visits to describe a child’s longitudinal development and applied cluster analysis to identify distinct patterns of these developmental trajectories. Results: The analyzed cohort included 1,130,005 children. The evaluation of the DSS on subpopulations of the cohort, stratified by known risk factors of developmental delays, revealed expected relations between developmental delay and characteristics of the child and mother, including demographics and obstetrics-related variables. On average, the score was worse for preterm children compared to full-term children and for male children compared to female children, and it was correspondingly worse for lower levels of maternal education. The trajectories of scores in 6 consecutive visits were available for 294,000 children. The clustering of these trajectories revealed 3 main types of developmental patterns that are consistent with clinical experience: children who successfully attain milestones, children who initially tend to fail but improve over time, and children whose failures tend to increase over time. Conclusions: The suggested score is straightforward to compute in its basic form and can be easily implemented as a web-based tool in its more elaborate form. It highlights known and novel relations between developmental delay and characteristics of the mother and child, demonstrating its potential usefulness for surveillance and research. Additionally, it can monitor the developmental trajectory of a child and characterize it. Future work is needed to calibrate the score vis-a-vis other screening tools, validate it worldwide, and integrate it into the clinical workflow of developmental surveillance.
- 18 August 2023
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 9, e47315
Open AccessA Developmental Surveillance Score for Quantitative Monitoring of Early Childhood Milestone Attainment: Algorithm Development and Validation
Background: Developmental surveillance, conducted routinely worldwide, is fundamental for timely identification of children at risk of developmental delays. It is typically executed by assessing age-appropriate milestone attainment and applying clinical judgment during health supervision visits. Unlike developmental screening and evaluation tools, surveillance typically lacks standardized quantitative measures, and consequently, its interpretation is often qualitative and subjective. Objective: Herein, we suggested a novel method for aggregating developmental surveillance assessments into a single score that coherently depicts and monitors child development. We described the procedure for calculating the score and demonstrated its ability to effectively capture known population-level associations. Additionally, we showed that the score can be used to describe longitudinal patterns of development that may facilitate tracking and classifying developmental trajectories of children. Methods: We described the Developmental Surveillance Score (DSS), a simple-to-use tool that quantifies the age-dependent severity level of a failure at attaining developmental milestones based on the recently introduced Israeli developmental surveillance program. We evaluated the DSS using a nationwide cohort of >1 million Israeli children from birth to 36 months of age, assessed between July 1, 2014, and September 1, 2021. We measured the score’s ability to capture known associations between developmental delays and characteristics of the mother and child. Additionally, we computed series of the DSS in consecutive visits to describe a child’s longitudinal development and applied cluster analysis to identify distinct patterns of these developmental trajectories. Results: The analyzed cohort included 1,130,005 children. The evaluation of the DSS on subpopulations of the cohort, stratified by known risk factors of developmental delays, revealed expected relations between developmental delay and characteristics of the child and mother, including demographics and obstetrics-related variables. On average, the score was worse for preterm children compared to full-term children and for male children compared to female children, and it was correspondingly worse for lower levels of maternal education. The trajectories of scores in 6 consecutive visits were available for 294,000 children. The clustering of these trajectories revealed 3 main types of developmental patterns that are consistent with clinical experience: children who successfully attain milestones, children who initially tend to fail but improve over time, and children whose failures tend to increase over time. Conclusions: The suggested score is straightforward to compute in its basic form and can be easily implemented as a web-based tool in its more elaborate form. It highlights known and novel relations between developmental delay and characteristics of the mother and child, demonstrating its potential usefulness for surveillance and research. Additionally, it can monitor the developmental trajectory of a child and characterize it. Future work is needed to calibrate the score vis-a-vis other screening tools, validate it worldwide, and integrate it into the clinical workflow of developmental surveillance.
- Open Access
- 23 May 2023
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 9 (3) , e85
Predicting future onset of depression among middle-aged adults with no psychiatric history
Background: Depression is a major cause of disability worldwide. Recent data suggest that, in industrialised countries, the prevalence of depression peaks in middle age. Identifying factors predictive of future depressive episodes is crucial for developing prevention strategies for this age group. Aims: We aimed to identify future depression in middle-aged adults with no previous psychiatric history. Method: To predict a diagnosis of depression 1 year or more following a comprehensive baseline assessment, we used a data-driven, machine-learning methodology. Our data-set was the UK Biobank of middle-aged participants (N = 245 036) with no psychiatric history. Results: Overall, 2.18% of the study population developed a depressive episode at least 1 year following baseline. Basing predictions on a single mental health questionnaire led to an area under the curve of the receiver operating characteristic of 0.66, and a predictive model leveraging the combined results of 100 UK Biobank questionnaires and measurements improved this to 0.79. Our findings were robust to demographic variations (place of birth, gender) and variations in methods of depression assessment. Thus, machine-learning-based models best predict diagnoses of depression when allowing the inclusion of multiple features. Conclusions: Machine-learning approaches show potential for being beneficial for the identification of clinically relevant predictors of depression. Specifically, we can identify, with moderate success, people with no recorded psychiatric history as at risk for depression by using a relatively small number of features. More work is required to improve these models and evaluate their cost-effectiveness before integrating them into the clinical workflow.
- 23 May 2023
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 9 (3) , e85
Open AccessPredicting future onset of depression among middle-aged adults with no psychiatric history
Background: Depression is a major cause of disability worldwide. Recent data suggest that, in industrialised countries, the prevalence of depression peaks in middle age. Identifying factors predictive of future depressive episodes is crucial for developing prevention strategies for this age group. Aims: We aimed to identify future depression in middle-aged adults with no previous psychiatric history. Method: To predict a diagnosis of depression 1 year or more following a comprehensive baseline assessment, we used a data-driven, machine-learning methodology. Our data-set was the UK Biobank of middle-aged participants (N = 245 036) with no psychiatric history. Results: Overall, 2.18% of the study population developed a depressive episode at least 1 year following baseline. Basing predictions on a single mental health questionnaire led to an area under the curve of the receiver operating characteristic of 0.66, and a predictive model leveraging the combined results of 100 UK Biobank questionnaires and measurements improved this to 0.79. Our findings were robust to demographic variations (place of birth, gender) and variations in methods of depression assessment. Thus, machine-learning-based models best predict diagnoses of depression when allowing the inclusion of multiple features. Conclusions: Machine-learning approaches show potential for being beneficial for the identification of clinically relevant predictors of depression. Specifically, we can identify, with moderate success, people with no recorded psychiatric history as at risk for depression by using a relatively small number of features. More work is required to improve these models and evaluate their cost-effectiveness before integrating them into the clinical workflow.
- Open Access
- 15 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Developmental Surveillance Score for Quantitative Monitoring of Early Childhood Milestone Attainment: Algorithm Development and Validation (Preprint)
BACKGROUND Developmental surveillance, conducted routinely worldwide, is fundamental for timely identification of children at risk of developmental delays. It is typically executed by assessing age-appropriate milestone attainment and applying clinical judgment during health supervision visits. Unlike developmental screening and evaluation tools, surveillance typically lacks standardized quantitative measures, and consequently, its interpretation is often qualitative and subjective. OBJECTIVE Herein, we suggested a novel method for aggregating developmental surveillance assessments into a single score that coherently depicts and monitors child development. We described the procedure for calculating the score and demonstrated its ability to effectively capture known population-level associations. Additionally, we showed that the score can be used to describe longitudinal patterns of development that may facilitate tracking and classifying developmental trajectories of children. METHODS We described the Developmental Surveillance Score (DSS), a simple-to-use tool that quantifies the age-dependent severity level of a failure at attaining developmental milestones based on the recently introduced Israeli developmental surveillance program. We evaluated the DSS using a nationwide cohort of >1 million Israeli children from birth to 36 months of age, assessed between July 1, 2014, and September 1, 2021. We measured the score’s ability to capture known associations between developmental delays and characteristics of the mother and child. Additionally, we computed series of the DSS in consecutive visits to describe a child’s longitudinal development and applied cluster analysis to identify distinct patterns of these developmental trajectories. RESULTS The analyzed cohort included 1,130,005 children. The evaluation of the DSS on subpopulations of the cohort, stratified by known risk factors of developmental delays, revealed expected relations between developmental delay and characteristics of the child and mother, including demographics and obstetrics-related variables. On average, the score was worse for preterm children compared to full-term children and for male children compared to female children, and it was correspondingly worse for lower levels of maternal education. The trajectories of scores in 6 consecutive visits were available for 294,000 children. The clustering of these trajectories revealed 3 main types of developmental patterns that are consistent with clinical experience: children who successfully attain milestones, children who initially tend to fail but improve over time, and children whose failures tend to increase over time. CONCLUSIONS The suggested score is straightforward to compute in its basic form and can be easily implemented as a web-based tool in its more elaborate form. It highlights known and novel relations between developmental delay and characteristics of the mother and child, demonstrating its potential usefulness for surveillance and research. Additionally, it can monitor the developmental trajectory of a child and characterize it. Future work is needed to calibrate the score vis-a-vis other screening tools, validate it worldwide, and integrate it into the clinical workflow of developmental surveillance.
- 15 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Developmental Surveillance Score for Quantitative Monitoring of Early Childhood Milestone Attainment: Algorithm Development and Validation (Preprint)
BACKGROUND Developmental surveillance, conducted routinely worldwide, is fundamental for timely identification of children at risk of developmental delays. It is typically executed by assessing age-appropriate milestone attainment and applying clinical judgment during health supervision visits. Unlike developmental screening and evaluation tools, surveillance typically lacks standardized quantitative measures, and consequently, its interpretation is often qualitative and subjective. OBJECTIVE Herein, we suggested a novel method for aggregating developmental surveillance assessments into a single score that coherently depicts and monitors child development. We described the procedure for calculating the score and demonstrated its ability to effectively capture known population-level associations. Additionally, we showed that the score can be used to describe longitudinal patterns of development that may facilitate tracking and classifying developmental trajectories of children. METHODS We described the Developmental Surveillance Score (DSS), a simple-to-use tool that quantifies the age-dependent severity level of a failure at attaining developmental milestones based on the recently introduced Israeli developmental surveillance program. We evaluated the DSS using a nationwide cohort of >1 million Israeli children from birth to 36 months of age, assessed between July 1, 2014, and September 1, 2021. We measured the score’s ability to capture known associations between developmental delays and characteristics of the mother and child. Additionally, we computed series of the DSS in consecutive visits to describe a child’s longitudinal development and applied cluster analysis to identify distinct patterns of these developmental trajectories. RESULTS The analyzed cohort included 1,130,005 children. The evaluation of the DSS on subpopulations of the cohort, stratified by known risk factors of developmental delays, revealed expected relations between developmental delay and characteristics of the child and mother, including demographics and obstetrics-related variables. On average, the score was worse for preterm children compared to full-term children and for male children compared to female children, and it was correspondingly worse for lower levels of maternal education. The trajectories of scores in 6 consecutive visits were available for 294,000 children. The clustering of these trajectories revealed 3 main types of developmental patterns that are consistent with clinical experience: children who successfully attain milestones, children who initially tend to fail but improve over time, and children whose failures tend to increase over time. CONCLUSIONS The suggested score is straightforward to compute in its basic form and can be easily implemented as a web-based tool in its more elaborate form. It highlights known and novel relations between developmental delay and characteristics of the mother and child, demonstrating its potential usefulness for surveillance and research. Additionally, it can monitor the developmental trajectory of a child and characterize it. Future work is needed to calibrate the score vis-a-vis other screening tools, validate it worldwide, and integrate it into the clinical workflow of developmental surveillance.
- Open Access
- 7 February 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 62 (8) , 920-937
Data-Driven Assessment of Adolescents’ Mental Health During the COVID-19 Pandemic
- 7 February 2023
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 62 (8) , 920-937
Open AccessData-Driven Assessment of Adolescents’ Mental Health During the COVID-19 Pandemic
- Open Access
- 15 March 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Distilling a High Precision Drug Adverse Effect Benchmark Using Wikipedia’s Wisdom of the Crowd (Preprint)
BACKGROUND Computational methods for identifying adverse events following medical interventions, require accurate and relevant “gold standard” for evaluation and comparison. An appealing possibility is to use datasets of adverse effects of drugs or vaccines. The available large datasets typically attain their size, by relying on automatic, or semi-automatic, methods for generation. This often comes with a compromise on the precision of the generated data, which can be at least partially alleviated by having experts curate the data. However, such a curation tends to be costly and time consuming. OBJECTIVE To improve accuracy without resorting to a manual curation, we aim to automatically extract the expert knowledge accumulated in Wikipedia, using Natural Language Processing technology. METHODS To curate a dataset of adverse drug effects (ADEs), we suggest retrieving the Wikipedia page associated with the drug, and checking whether the ADE appears in the sections describing adverse effects. RESULTS We use this method to distill two large adverse drug effect datasets – SIDER and OFFSIDES – and evaluate the obtained datasets versus their originating ones over two small ground-truth sets. For example, distilling the SIDER dataset to 7.2% of its size, and evaluating the result on a ground-truth derived from clinical trials, improves precision from 0.14 to 0.86, and F1-score from 0.23 to 0.75. CONCLUSIONS To accurately evaluate and compare algorithms which infer drug-ADE relations, there is a need for high-precision benchmark sets. The method suggested here is shown to yield such sets, and may be of more general use in distilling medical data.
- 15 March 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDistilling a High Precision Drug Adverse Effect Benchmark Using Wikipedia’s Wisdom of the Crowd (Preprint)
BACKGROUND Computational methods for identifying adverse events following medical interventions, require accurate and relevant “gold standard” for evaluation and comparison. An appealing possibility is to use datasets of adverse effects of drugs or vaccines. The available large datasets typically attain their size, by relying on automatic, or semi-automatic, methods for generation. This often comes with a compromise on the precision of the generated data, which can be at least partially alleviated by having experts curate the data. However, such a curation tends to be costly and time consuming. OBJECTIVE To improve accuracy without resorting to a manual curation, we aim to automatically extract the expert knowledge accumulated in Wikipedia, using Natural Language Processing technology. METHODS To curate a dataset of adverse drug effects (ADEs), we suggest retrieving the Wikipedia page associated with the drug, and checking whether the ADE appears in the sections describing adverse effects. RESULTS We use this method to distill two large adverse drug effect datasets – SIDER and OFFSIDES – and evaluate the obtained datasets versus their originating ones over two small ground-truth sets. For example, distilling the SIDER dataset to 7.2% of its size, and evaluating the result on a ground-truth derived from clinical trials, improves precision from 0.14 to 0.86, and F1-score from 0.23 to 0.75. CONCLUSIONS To accurately evaluate and compare algorithms which infer drug-ADE relations, there is a need for high-precision benchmark sets. The method suggested here is shown to yield such sets, and may be of more general use in distilling medical data.